![]() phosphocyclocreatine structure
|
Common Name | phosphocyclocreatine | ||
---|---|---|---|---|
CAS Number | 61839-19-8 | Molecular Weight | 223.12400 | |
Density | 2.03g/cm3 | Boiling Point | 481ºC at 760 mmHg | |
Molecular Formula | C5H10N3O5P | Melting Point | N/A | |
MSDS | N/A | Flash Point | 244.7ºC |
Use of phosphocyclocreatineCyclocreatine phosphate is an anti-tumor agent. Cyclocreatine phosphate is the proposed active form of cyclocreatine (CCr), a substrate analogue of creatine kinase. Cyclocreatine phosphate has anti-tumour activity and can be used for the research of cancer[1]. |
Name | 2-(2-imino-3-phosphonoimidazolidin-1-yl)acetic acid |
---|---|
Synonym | More Synonyms |
Description | Cyclocreatine phosphate is an anti-tumor agent. Cyclocreatine phosphate is the proposed active form of cyclocreatine (CCr), a substrate analogue of creatine kinase. Cyclocreatine phosphate has anti-tumour activity and can be used for the research of cancer[1]. |
---|---|
Related Catalog | |
In Vivo | Cyclocreatine phosphate (CCr'P) (i.p.; 37.5 mg/mL; 0.2 mL, twice daily) has anti-tumor activity without any notable signs of toxicity in a mouse xenograft model for human prostate cancer[1]. Animal Model: Athymic (CDl-Nu/Nu) male mice[1] Dosage: 37.5 mg/mL Administration: intraperitoneally , 0.2 mL, twice daily Result: Showed anti-tumor effect. |
References |
Density | 2.03g/cm3 |
---|---|
Boiling Point | 481ºC at 760 mmHg |
Molecular Formula | C5H10N3O5P |
Molecular Weight | 223.12400 |
Flash Point | 244.7ºC |
Exact Mass | 223.03600 |
PSA | 134.97000 |
Index of Refraction | 1.733 |
Phosphocyclocreatine |
N-Phosphorylcyclocreatine |
[(2e)-2-imino-3-phosphonoimidazolidin-1-yl]acetic acid |
Cyclocreatine phosphate |